Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2000-05-04
2002-05-07
Berch, Mark L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C540S228000, C540S225000
Reexamination Certificate
active
06384212
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates in general to a new, simple, and easy process for preparing cephalosporin antibiotics including ceftazidime, cefixime, and the like. More particularly, the present invention relates to a process for the preparation of cephalosporin antibiotics of the following formula (I), in which a 7-amino cephalosporanic acid derivative of the following formula (III) is acylated by reaction with a new crystalline aminothiazole derivative of the following formula (II) in a solvent:
wherein R
1
and R
2
are the same or different and independently represent H, an alkyl group of 1 to 4 carbon atoms, or a cycloalkyl group of 3 to 5 carbon atoms, etc., R
4
represents acetoxymethyl, pyridiniummethyl, or vinyl, COOM is COO
−
when R
4
is pyridiniummethyl and COOH otherwise, and X represents chlorine or bromine. Moreover, the acid in the acid addition salt as shown in the formula (II) represents an inorganic acid, such as hydrochloric acid, hydrobromic acid, sulfuric acid, or perchloric acid, etc., or an organic acid, such as formic acid, acetic acid, trifluoroacetic acid, propionic acid, methanesulfonic acid, or benzenesulfonic acid, etc.
2. Description of the Prior Art
Processes for the preparation of cephalosporin antibiotics of the above formula (I), including ceftazidime and cefixime, were disclosed in several literatures and patents, for example, U.S. Pat. No. 4,258,041; Austrian Patent Publication Nos. 86-2427 and 86-2428
; J. of Antibiotics
, Vol.38, pp. 1738, 1985; and Korean Patent Publication Nos. 84-1827, 84-1987, 84-1988, 84-1989, 84-1990, 87-1807, and 93-7810.
In the above prior processes, an amino group of a 3-cephem compound represented by the following formula (I-1) is acylated by reaction with a 2-aminothiazol carboxylic acid of the following formula (I-2) or a salt or reactive derivative thereof to produce the cephalosporin derivative of the formula
where R
1
, R
2
, and R
4
have the same meanings as described above, R
3
is a carboxy protecting group, R
a
is hydrogen or an amino protecting group, R
b
is hydrogen or a carboxy protecting group, such as diphenylmethyl or p-nitrobenzene.
U.S. Pat. No. 4,258,041, and Korean Patent Publication No. 84-1827, etc. describe processes employing acid chloride of the organic acid (I-2) in the acylation reaction with the 7-amino cephalosporin derivative of the formula (I-1). According to these processes, the organic acid (I-2) is conventionally protected on an amino group of its thiazole ring, and then converted to its acid chloride with thionyl chloride, phosphorus oxychloride, or phosphorus pentachloride, etc. Thereafter, the resulting acid chloride of the organic acid (I-2) is reacted with the 7-amino cephalosporanic acid derivative, followed by removing the protecting group on the amino group of the thiazole ring. However, these processes have disadvantages in that they are carried out under strict reaction conditions, and further require a step of protecting the amino group of the thiazole ring and a step of removing the protecting group on the amino group. In addition, another drawback with these processes is that the aminothiazole compound activated with unstable acid chloride is acylated as such without being subjected to an isolation step, such that by-products are significantly produced during the acylation reaction owing to the unstable acid chloride.
Austrian Patent Publication Nos. 86-2427 and 86-2428, and WO No. 98-31685, etc. disclose processes in which a reactive ester of the organic acid (I-2) is prepared and acylated. In this acylation, the reactive ester of the organic acid (I-2) may be reacted with the 7-aminocephalosporin derivative without the protecting group on the amino group of its thiazole ring. However, it is necessary for these processes to remove a protecting group on a carboxy group of the aminothiazole compound (I-2) after the acylation reaction, in order to give the final desired compound.
In addition, there are also known other processes employing a reactive amide or a mixed acid anhydride, but they have drawbacks similar to those in the above processes.
Therefore, in the case of carrying out the acylation reaction using the reactive derivative (e.g., the acid chloride) as described above, the amino and carboxyl groups of the compound of the formula (I-2) must be protected with R
a
other hand, in the case of using the reactive ester, the preparation of the reactive ester must be carried out in a state where the amino group is not protected, but the carboxyl group is protected with R
3
. As a result, all the processes according to the prior art have a drawback in that the deprotection must be carried out after the acylation reaction.
SUMMARY OF THE INVENTION
We have discovered that, when an aminothiazole compound represented by the following formula II was acylated by reaction with a 7-amino cephalosporanic acid derivative represented by the following formula (III) in a solvent as indicated in the following reaction scheme, a desired compound could be directly obtained in a high yield in a simple and easy way without a need of the deprotection after the acylation reaction, whereby we have perfected the present invention based on this discovery:
wherein R
1
, R
2
, R
4
, and the acid addition salt have the same meaning as defined above.
It is therefore an object of the present invention to provide a process for preparing cephalosporin antibiotics including ceftazidime and cefixime, etc., using a new aminothiazole compound represented by the formula (II).
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The foregoing and other objects, features and advantages of the invention will be apparent to those skilled in the art to which the present invention relates from reading the following specification.
The aminothiazole compound of the formula (II) used as the starting material in the practice of the present invention is a new material and a reactive derivative in the form of a crystalline acid chloride. Thus, this is more stable and can be stored over a lengthy period of time at a low temperature and room temperature, as compared with the conventional acid chloride. Moreover, the process of the present invention produces little or no by-products in the acylation reaction of the 7-aminocephalosporin derivative with the compound of the formula (II), and is also relatively short in reaction time. Additionally, the process of the present invention employing this compound of the formula (II) does not require the removal of the protecting group after the acylation, and allows the desired compound to be directly obtained after the acylation. As a result, the process of the present invention makes the acylation reaction more economical and also simple and easy.
The new aminothiazole derivative of the formula (II) is described in detail in Korean Patent Application No.2000-11127 (Filing date: Mar. 6 2000; Name of Applicant: HANMI FINE CHEMICALS, CO., LTD; and Title: New thiazole compounds and a process thereof), the disclosure of which is incorporated herein by reference. Moreover, among the derivatives of the formula (III), a 3-vinyl-7-aminocephalosporanic acid and a 3-pyridiniummethyl-7-aminocephalosporanic acid mentioned herein are known compounds and described in detail in several literatures, for example, U.S. Pat. No. 4,423,213, Korean Patent No. 127,113, and British Patent No. 2,052,490, the disclosure of which is incorporated herein by reference.
In the acylation reaction according to the present invention, the compound of the formula (II) is used in the amount of 1.0 to 2.0 equivalents, and preferably 1.2 to 1.4 equivalents, relative to the compound of the formula (III).
The solvent which can be used in the practice of the present invention includes, for example, dichloromethane, dichloroethane, chloroform, acetonitrile, tetrahydrofuran, N,N-dimethylacetamide, N,N-dimethylformamide, methanol, ethanol, or a combination thereof. However, a solution adjuvant, such as N,O-bistrimethylsilylacetamide, trimethylchlorosila
Lee Ju Cheol
Lee Myoung Ki
Lee Yoon Seok
Oh Sang Mi
Park Mi Soon
Berch Mark L.
Hanmi Fine Chemicals Co., Ltd.
Schmidt Richard D.
Venable
LandOfFree
Process for preparing cephalosporin antibiotics using new... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing cephalosporin antibiotics using new..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing cephalosporin antibiotics using new... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2903656